DBV Technologies SA (DBVT)
0.6651
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
0.665
0.00 (0.00%)
Pre-Market: 20:00
DBV Technologies Enterprise Value: -12.56M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | -12.56M |
| April 30, 2024 | -13.23M |
| April 29, 2024 | -7.536M |
| April 26, 2024 | -9.306M |
| April 25, 2024 | -7.873M |
| April 24, 2024 | -7.575M |
| April 23, 2024 | -9.690M |
| April 22, 2024 | -13.34M |
| April 19, 2024 | -9.363M |
| April 18, 2024 | -13.34M |
| April 17, 2024 | -9.690M |
| April 16, 2024 | -5.728M |
| April 15, 2024 | -6.805M |
| April 12, 2024 | -6.911M |
| April 11, 2024 | -5.844M |
| April 10, 2024 | -2.074M |
| April 09, 2024 | 0.6961M |
| April 08, 2024 | 7.640M |
| April 05, 2024 | 7.620M |
| April 04, 2024 | -5.844M |
| April 03, 2024 | 3.774M |
| April 02, 2024 | 6.640M |
| April 01, 2024 | 9.544M |
| March 28, 2024 | 3.656M |
| March 27, 2024 | 7.043M |
| Date | Value |
|---|---|
| March 26, 2024 | 8.890M |
| March 25, 2024 | 10.54M |
| March 22, 2024 | 12.72M |
| March 21, 2024 | 13.45M |
| March 20, 2024 | 15.37M |
| March 19, 2024 | 12.68M |
| March 18, 2024 | 7.678M |
| March 15, 2024 | 11.53M |
| March 14, 2024 | 15.93M |
| March 13, 2024 | 19.42M |
| March 12, 2024 | 25.26M |
| March 11, 2024 | 23.07M |
| March 08, 2024 | 24.61M |
| March 07, 2024 | 18.45M |
| March 06, 2024 | 23.51M |
| March 05, 2024 | 22.09M |
| March 04, 2024 | 23.46M |
| March 01, 2024 | 19.22M |
| February 29, 2024 | 17.30M |
| February 28, 2024 | 14.16M |
| February 27, 2024 | 18.65M |
| February 26, 2024 | 20.95M |
| February 23, 2024 | 20.95M |
| February 22, 2024 | 16.34M |
| February 21, 2024 | 15.39M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-100.94M
Minimum
Oct 28 2020
1.030B
Maximum
Jan 10 2020
261.21M
Average
174.57M
Median
May 17 2023
Enterprise Value Benchmarks
| Edap TMS SA | 223.52M |
| Cellectis SA | 12.27M |
| Biophytis SA | 2.443M |
| Genfit SA | 156.58M |
| Adaptimmune Therapeutics PLC | 149.25M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.19M |
| Total Expenses (Quarterly) | 12.02M |
| EPS Diluted (Quarterly) | -0.055 |
| Earnings Yield | -57.13% |